Estrella Immunopharma (ESLA) Return on Assets (2021 - 2026)
Estrella Immunopharma (ESLA) posted quarterly Return on Assets of 0.03% for Q1 2026, up 4.0% year-over-year from 0.03% in Q1 2025, and little changed quarter-over-quarter from 0.03% in Q4 2025.
Estrella Immunopharma (ESLA) Return on Assets (2021 - 2026) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Return on Assets for 6 consecutive years, with 0.03% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets rose 4.0% year-over-year to 0.03%; the TTM figure through Mar 2026 stood at 0.03% (up 4.0% YoY), while the FY2025 annual figure was 0.03%, down 1.0% from the prior year.
- Return on Assets was little changed at 0.03% in Q1 2026 per ESLA's latest filing, from 0.03% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q1 2022 and bottomed at 0.07% in Q2 2025.
- Historically, Return on Assets has averaged 0.02% across 5 years, with a median of 0.02% in 2023.
- Annual changes were most pronounced in 2025 — Return on Assets dropped 6 bps — and 2026, when it grew 4 bps.
- Estrella Immunopharma's Return on Assets stood at 0.0% in 2022, then plunged by 162 bps to 0.01% in 2023, then sank by 701 bps to 0.05% in 2024, then surged by 38 bps to 0.03% in 2025, then gained by 0 bps to 0.03% in 2026.
- Business Quant data shows ESLA's Return on Assets at 0.03% in Q1 2026, 0.03% in Q4 2025, and 0.05% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.00% |
| 10 | Estrella Immunopharma | 32.29 Mn | 32.14 Mn | - | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.03% |
| Mar 31, 2026 | -0.03% |
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.05% |
| Jun 30, 2025 | -0.07% |
| Mar 31, 2025 | -0.07% |
| Dec 31, 2024 | -0.05% |
| Sep 30, 2024 | -0.03% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |